Evidence map›Paper›PMID 39047509›Full record

ArticleJournal of the neurological sciences2024

Long-term outcomes of patients affected by Guillain-Barré syndrome in Colombia after the Zika virus epidemic.

David Acero-Garces, Daniela Zuluaga-Lotero, Daniela Ortiz-Muñoz, Gloria P Arango, Martha Moyano, José Vargas-Manotas, Christian A Rojas, Jonathan Urrego, Juan P Rojas, Fernando Rosso and 17 more

Abstract read
In one paragraph

Article in Journal of the neurological sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Flaviviruses-Induced Neurological Sequelae.Pathogens (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

David Acero-GarcesUniversidad del Valle, Department of Microbiology, Cali, Colombia.
Daniela Zuluaga-LoteroUniversidad del Valle, Department of Microbiology, Cali, Colombia.
Daniela Ortiz-MuñozUniversidad del Valle, Department of Microbiology, Cali, Colombia.
Gloria P ArangoUniversidad Del Valle, School of Human Rehabilitation, Faculty of Health, Cali, Colombia.
Martha MoyanoUniversidad Del Valle, School of Public Health, Cali, Colombia.
José Vargas-ManotasUniversidad Simón Bolívar, Barranquilla, Colombia; La Misericordia Clínica Internacional, Barranquilla, Colombia.
Christian A RojasUniversidad del Valle, School of Medicine, Cali, Colombia; Hospital Universitario del Valle, Cali, Colombia; Clinica Imbanaco, Department of Pediatrics, Cali, Colombia.
Jonathan UrregoUniversidad del Valle, School of Medicine, Cali, Colombia; Hospital Universitario del Valle, Cali, Colombia.
Juan P RojasFundación Clínica Infantil Club Noel, Department of Pediatrics, Cali, Colombia; Universidad Libre seccional Cali, Cali, Colombia.
Fernando RossoFundación Valle del Lili, Department of Internal Medicine, Cali, Colombia; Universidad ICESI, Cali, Colombia.
Gustavo E Ramos-BurbanoUniversidad del Valle, School of Medicine, Cali, Colombia; Clinica Rey David, Cali, Colombia.
Mario Daniel LlanosClinica Rey David, Cali, Colombia.
Jairo LizarazoHospital Universitario Erasmo Meoz, Cúcuta, Colombia; Universidad de Pamplona, Cúcuta, Colombia.
Reydmar Lopez-GonzalezHospital San Vicente Fundación Rionegro, Universidad de Antioquia, Medellin, Colombia.
Jorge A Jimenez-ArangoUniversidad de Antioquia, Hospital Alma Máter de Antioquia, Medellin, Colombia.
Julie Benavides-MeloUniversidad Cooperativa de Colombia, School of Medicine, Pasto, Colombia.
Viviana A Martinez-VillotaHospital Universitario Departamental de Nariño, Pasto, Colombia.
Guillermo GonzalezHospital Universitario de Neiva Hernando Moncaleano Perdomo, Neiva, Colombia; Universidad Surcolombiana, Neiva, Colombia.
Susana C Dominguez-PenuelaJohns Hopkins University School of Medicine, Department of Neurology, Baltimore, MD, USA.
Jaime A QuinteroUniversidad del Valle, Department of Microbiology, Cali, Colombia.
Karina A LuqueHospital Universitario Erasmo Meoz, Cúcuta, Colombia.
Adriana M RuizHospital Universitario Erasmo Meoz, Cúcuta, Colombia.
Katherinne ClarosHospital Universitario de Neiva Hernando Moncaleano Perdomo, Neiva, Colombia.
Lyda OsorioUniversidad Del Valle, School of Public Health, Cali, Colombia.
Carlos A PardoJohns Hopkins University School of Medicine, Department of Neurology, Baltimore, MD, USA; Johns Hopkins University School of Medicine, Department of Pathology, Baltimore, MD, USA. Electronic address: cpardov1@jhmi.edu.
Beatriz ParraUniversidad del Valle, Department of Microbiology, Cali, Colombia.
Neuroinfections Emerging in the Americas Study (NEAS)

Funding

Emerging Neuroviruses and Neurological Inflammatory DiseasesR01NS110122 · NINDS · JOHNS HOPKINS UNIVERSITY · PI PARDO-VILLAMIZAR, CARLOS A · 2019 to 2023
$1.7M
NINDS NIH HHS R01 NS110122
6 · The paper itself

Abstract

backgroundGuillain-Barré Syndrome (GBS) can lead to significant functional impairments, yet little is understood about the recovery phase and long-term consequences for patients in low- and medium-income countries.

objectiveTo evaluate the functional status and identify factors influencing outcomes among patients with GBS in Colombia.

methodsTelephone interviews were conducted with GBS patients enrolled in the Neuroviruses Emerging in the Americas Study between 2016 and 2020. The investigation encompassed access to health services and functional status assessments, utilizing the modified Rankin Scale (mRS), GBS Disability Score (GDS), Barthel Index (BI), and International Classification of Functioning (ICF). Univariate analysis, principal component analysis, linear discriminant analysis, and linear regression were employed to explore factors influencing functional status.

resultsForty-five patients (mean age = 50[±22] years) with a median time from diagnosis of 28 months (IQR = 9-34) were included. Notably, 22% and 16% of patients did not receive rehabilitation services during the acute episode and post-discharge, respectively. Most patients demonstrated independence in basic daily activities (median BI = 100, IQR = 77.5-100), improvement in disability as the median mRS at follow-up was lower than at onset (1 [IQR = 0-3] vs. 4.5 [IQR = 4-5], p < 0.001), and most were able to walk without assistance (median GDS = 2, IQR = 0-2). A shorter period from disease onset to interview was associated with worse mRS (p = 0.015) and ICF (p = 0.019). Negative outcomes on GDS and ICF were linked to low socioeconomic status, ICF to the severity of weakness at onset, and BI to an older age.

conclusionsThis study underscores that the functional recovery of GBS patients in Colombia is influenced not only by the natural course of the disease but also by socioeconomic factors, emphasizing the crucial role of social determinants of health.

Indexed as

Guillain-Barre SyndromeZika Virus InfectionAdultAgedColombiaDisability EvaluationEpidemicsFemaleFunctional StatusHumansMaleMiddle AgedRecovery of FunctionActivities of daily livingGuillain-Barré syndromeLow- and middle-income countriesNeurological rehabilitationPeripheral nervesPolyneuropathiesQuality of lifeRecovery of function

Identifiers

PMID39047509
PMCPMC11338696

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.